guess who merial is working with?, page-4

ogtr Preparations are underway for initial production of product material for registration in the major global markets. A final optimisation step is required before production of initial batches commences. We expect this material to be available for the upcoming intentional release trials. The timing of these trials depends on regulatory approval timing of the OGTR. Our application for the ‘Intentional release license’ from the Commonwealth Government’s OGTR has advanced. This license is a precursor to large commercial field trials and commercial sales of the Poultry Productivity Enhancer in Australia. While regulatory trials can proceed without this license, Imugene has identified significant marketing value in obtaining this license early to enable trials to be undertaken by commercial poultry producers to boost the products marketing value. Importantly, the product development timetable is proceeding while the OGTR considers the terms of the license
Imugene is now in the final stages of responding to the OGTR review. Once Imugene’s response is submitted, the OGTR will conduct a final review and release its assessment decision. A series of field trials with the Poultry Productivity Enhancer will be performed under typical commercial poultry shed conditions. The results will be the basis for marketing the product’s superior efficacy to commercial poultry farmers worldwide. It is anticipated these trials will begin immediately following receipt of the OGTR license. Sub-licensing negotiations for the Poultry Productivity Enhancer advanced towards completion during the quarter. Much has been achieved in finalising a detailed product development plan for the sub-license to minimise time to commercial release and streamline the global rollout. These negotiations have added essential detail to the principal terms agreed within the Option Agreement signed in 2002. Planning is well into product development issues including managing manufacturing and regulatory trial schedules